Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease

Coresh, 2003, Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey, Am J Kidney Dis, 41, 1, 10.1053/ajkd.2003.50007 McClellan, 1997, Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients: Important differences between practice and published guidelines, Am J Kidney Dis, 29, 368, 10.1016/S0272-6386(97)90197-9 Kausz, 2001, Management of patients with chronic renal insufficiency in the northeastern United States, J Am Soc Nephrol, 12, 1501, 10.1681/ASN.V1271501 Coresh, 2001, Prevalence of high blood pressure and elevated serum creatinine level in the United States: Findings from the Third National Health and Nutrition Examination Survey (1988–1994), Arch Int Med, 161, 1207, 10.1001/archinte.161.9.1207 National Kidney Foundation, 2002, Clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification [abstract], Am J Kidney Dis, 39, S1 Clinical Practice Guidelines for Chronic Kidney Disease, 2002, Evaluation, classification, and stratification, Am J Kidney Dis, 39, S17 Shlipak, 2001, Renal insufficiency and cardiovascular events in post-menopausal women with coronary heart disease, J Am Coll Cardiol, 38, 705, 10.1016/S0735-1097(01)01450-4 Mann, 2001, Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial, Ann Int Med, 134, 629, 10.7326/0003-4819-134-8-200104170-00007 Dries, 2002, The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventrical systolic dysfunction [abstract], J Am Coll Cardiol, 35, 681, 10.1016/S0735-1097(99)00608-7 McCullough, 2000, Risks associated with renal dysfunction in patients in the coronary care unit [abstract], J Am Coll Cardiol, 36, 679, 10.1016/S0735-1097(00)00774-9 Matts, 1993, Serum creatinine as an independent predictor of coronary heart disease mortality in normotensive survivors of myocardial infarction [abstract], J Fam Practice, 36, 497 Muntner, 2002, Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States, J Am Soc Nephrol, 13, 745, 10.1681/ASN.V133745 Manjunath, 2003, Level of kidney function as a risk factor for cardiovascular outcomes in the elderly, Kidney Int, 63, 1121, 10.1046/j.1523-1755.2003.00838.x Stenvinkel, 1999, Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure, Kidney Int, 51, 1899, 10.1046/j.1523-1755.1999.00422.x Arici, 2001, End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?, Kidney Int, 59, 407, 10.1046/j.1523-1755.2001.059002407.x Stenvinkel, 2001, Inflammatory and atherosclerotic interactions in the depleted uremic patient, Blood Purif, 10, 53, 10.1159/000014479 Himmelfarb, 2002, The elephant in uremia: Reflections on oxidant stress as a unifying concept, Kidney Int, 62, 1524, 10.1046/j.1523-1755.2002.00600.x Levey, 1999, A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group, Ann Int Med, 130, 461, 10.7326/0003-4819-130-6-199903160-00002 Ellman, 1959, Tissue sulfhydryl groups, Archives of Biochemistry and Biophysics, 82, 70, 10.1016/0003-9861(59)90090-6 Hu, 1993, Antioxidant protection against hypochlorous acid in human plasma, J Lab Clin Med, 121, 257 Himmelfarb, 2000, Plasma protein thiol oxidation and carbonyl formation in chronic renal failure, Kidney Int, 58, 2571, 10.1046/j.1523-1755.2000.00443.x Buss, 1997, Protein carbonyl measurement by a sensitive ELISA method, Free Radical Biology & Medicine, 23, 361, 10.1016/S0891-5849(97)00104-4 Winterbourn, 1999, Protein carbonyl measurement by enzyme-linked immunosorbent assay, Methods in Enzymology, 300, 106, 10.1016/S0076-6879(99)00118-4 Morrow, 1999, The isoprostanes: Unique prostaglandin-like products of free-radical-initiated lipid peroxidation, Drug Metab Rev, 31, 117, 10.1081/DMR-100101910 Vanholder, 2001, Uremic toxicity: Present state of the art, Int J Artif Organs, 24, 695, 10.1177/039139880102401004 Dubourg, 2001, Human kidney tubules detoxify chloroacetaldehyde, a presumed nephrotoxic metabolite of ifosfamide, J Am Soc Nephrol, 12, 1615, 10.1681/ASN.V1281615 Michoudet, 1987, Metabolism of acetaldehyde in human and baboon renal cortex, FEBS Lett, 216, 113, 10.1016/0014-5793(87)80767-6 Silbernagl, 1972, The tubular reabsorption of L-cystine and L-cysteine: A common transport system with L-arginine or not?, Pflugers Arch, 337, 227 Heuner, 1988, Renal handling of glutathione, Contr Nephrol, 63, 49, 10.1159/000415698 Völkl, 1982, Reexamination of the interplay between dibasic amino acids and L-cystine/L-cysteine during tubular reabsorption, Pflugers Arch, 395, 196, 10.1007/BF00584809 Stuveling, 2003, C-reactive protein is associated with renal function abnormalities in a non-diabetic population, Kidney Int, 63, 654, 10.1046/j.1523-1755.2003.00762.x Pecoits-Filho, 2003, Associations between circulating inflammatory markers and residual renal function in CRF patients, Am J Kidney Dis, 41, 1212, 10.1016/S0272-6386(03)00353-6 Panichi, 2002, C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure, Nephron, 91, 594, 10.1159/000065018 Descamps-Latscha, 1995, Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes, J Immunol, 154, 882, 10.4049/jimmunol.154.2.882 Shlipak, 2003, Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency, Circulation, 107, 87, 10.1161/01.CIR.0000042700.48769.59 Sarnak, 2002, Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study, Kidney Int, 62, 2208, 10.1046/j.1523-1755.2002.00677.x Davies, 1999, Stable markers of oxidant damage to proteins and their application in the study of human disease, Free Rad Biol Med, 27, 1151, 10.1016/S0891-5849(99)00206-3 Uchida, 2000, Role of reactive aldehyde in cardiovascular diseases, Free Rad Biol Med, 28, 1685, 10.1016/S0891-5849(00)00226-4 Miyata, 1998, Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: Carbonyl stress in uremia, J Am Soc Nephrol, 9, 2349, 10.1681/ASN.V9122349 Handelman, 2001, Elevated plasma F2-isoprostanes in patients on long-term hemodialysis, Kidney Int, 51, 1960, 10.1046/j.1523-1755.2001.0590051960.x Ikizler, 2002, Plasma F2 isoprostane levels are elevated in chronic hemodialysis patients, Clin Nephrol, 88, 190, 10.5414/CNP58190 Annuk, 2001, Oxidative stress and endothelial function in chronic renal failure, J Am Soc Nephrol, 12, 2747, 10.1681/ASN.V12122747 Bolton, 2001, Endothelial dysfunction in chronic renal failure: Roles of lipoprotein oxidation and pro-inflammatory cytokines, Nephrol Dial Transplant, 16, 1189, 10.1093/ndt/16.6.1189 Mezzano, 2001, Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia, Kidney Int, 60, 1844, 10.1016/S0085-2538(15)48065-2 Witko-Sarsat, 1998, Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure, J Immunol, 161, 2524, 10.4049/jimmunol.161.5.2524 Griendling, 1994, Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells, Circ Res, 74, 1141, 10.1161/01.RES.74.6.1141 Wingler, 2001, Upregulation of the vascular NAD(P)H-oxidase isoforms NOX1 and NOX4 by the renin-angiotensin system in vitro and in vivo, Free Rad Biol Med, 31, 1456, 10.1016/S0891-5849(01)00727-4 Deng, 2001, Increased tyrosine nitration of the brain in chronic renal insufficiency: Reversal of antioxidant therapy and angiotensin-converting enzyme inhibition, J Am Soc Nephrol, 12, 1892, 10.1681/ASN.V1291892 Andersson, 2002, Captopril-impaired production of tumor necrosis factor-α-induced interleukin-1β in human monocytes is associated with altered intracellular distribution of nuclear factor-KB, J Lab Clin Med, 140, 103, 10.1016/S0022-2143(02)00024-0 Miyata, 2002, Angiogensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: Biochemical mechanisms, J Am Soc Nephrol, 13, 2478, 10.1097/01.ASN.0000032418.67267.F2 Stenvinkel, 1999, Do ACE-inhibitors suppress tumour necrosis factor-alpha production in advanced chronic renal failure?, J Intern Med, 246, 503, 10.1046/j.1365-2796.1999.00560.x Ridker, 1999, Long-term effects of Pravastatin on plasma concentration of C-reactive protein, Circulation, 100, 230, 10.1161/01.CIR.100.3.230 Ridker, 1998, Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels, Circulation, 98, 839, 10.1161/01.CIR.98.9.839 Ridker, 2001, Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events, N Engl J Med, 344, 1959, 10.1056/NEJM200106283442601